ES2065254A1 - Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados. - Google Patents

Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.

Info

Publication number
ES2065254A1
ES2065254A1 ES09300117A ES9300117A ES2065254A1 ES 2065254 A1 ES2065254 A1 ES 2065254A1 ES 09300117 A ES09300117 A ES 09300117A ES 9300117 A ES9300117 A ES 9300117A ES 2065254 A1 ES2065254 A1 ES 2065254A1
Authority
ES
Spain
Prior art keywords
peptides
related viruses
canine parvovirus
vaccines against
against canine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09300117A
Other languages
English (en)
Other versions
ES2065254B1 (es
Inventor
Alvarez Jose Ignacio Casal
Olmo Carmen Vela
Joannes Pieter Langeveld
Robert Hans Meloen
Kristian Dalsgaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inmunologia y Genetica Aplicada SA
Original Assignee
Inmunologia y Genetica Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES9300117A priority Critical patent/ES2065254B1/es
Application filed by Inmunologia y Genetica Aplicada SA filed Critical Inmunologia y Genetica Aplicada SA
Priority to AU70048/94A priority patent/AU680264B2/en
Priority to CA002132742A priority patent/CA2132742C/en
Priority to US08/307,724 priority patent/US5785974A/en
Priority to NZ259882A priority patent/NZ259882A/en
Priority to DE69415462T priority patent/DE69415462T2/de
Priority to AT94905108T priority patent/ATE174929T1/de
Priority to EP94905108A priority patent/EP0647655B1/en
Priority to PCT/ES1994/000006 priority patent/WO1994017098A1/es
Priority to DK94905108T priority patent/DK0647655T3/da
Publication of ES2065254A1 publication Critical patent/ES2065254A1/es
Application granted granted Critical
Publication of ES2065254B1 publication Critical patent/ES2065254B1/es
Priority to GR990400812T priority patent/GR3029727T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PEPTIDOS Y VACUNAS SINTETICAS CONTRA PARVOVIRUS CANINO Y OTROS VIRUS RELACIONADOS. SE DESCRIBEN PEPTIDOS SINTETICOS CAPACES DE PRODUCIR ANTICUERPOS NEUTRALIZANTES CONTRA PARVOVIRUS CANINO (CPV). ESTOS PEPTIDOS CORRESPONDEN A SITIOS ANTIGENICOS LOCALIZADOS EN EL EXTREMO AMINO TERMINAL DE LA VP2 DE CPV QUE, ACOPLADOS A PROTEINAS TRANSPORTADORAS U OTROS COMPLEJOS INMUNOGENICOS, RESULTAN UTILES PARA FORMULAR VACUNAS CONTRA CPV Y OTROS VIRUS RELACIONADOS TALES COMO EL VIRUS DE LA PANLEUCOPENIA FELINA (FPLV) Y EL VIRUS DE LA ENTERITIS DE LOS VISONES (MEV).
ES9300117A 1993-01-23 1993-01-23 Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados. Expired - Fee Related ES2065254B1 (es)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ES9300117A ES2065254B1 (es) 1993-01-23 1993-01-23 Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.
PCT/ES1994/000006 WO1994017098A1 (es) 1993-01-23 1994-01-21 Peptidos y vacunas sinteticos contra parvovirus
US08/307,724 US5785974A (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
NZ259882A NZ259882A (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvoviruses
DE69415462T DE69415462T2 (de) 1993-01-23 1994-01-21 Synthetischen peptiden und impfstoffe gegen parvovirus
AT94905108T ATE174929T1 (de) 1993-01-23 1994-01-21 Synthetischen peptiden und impfstoffe gegen parvovirus
AU70048/94A AU680264B2 (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
CA002132742A CA2132742C (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
DK94905108T DK0647655T3 (da) 1993-01-23 1994-01-21 Syntetiske peptider og vacciner mod parvovirus
EP94905108A EP0647655B1 (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
GR990400812T GR3029727T3 (en) 1993-01-23 1999-03-18 Synthetic peptides and vaccines against parvovirus.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9300117A ES2065254B1 (es) 1993-01-23 1993-01-23 Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.

Publications (2)

Publication Number Publication Date
ES2065254A1 true ES2065254A1 (es) 1995-02-01
ES2065254B1 ES2065254B1 (es) 1995-07-16

Family

ID=8280539

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9300117A Expired - Fee Related ES2065254B1 (es) 1993-01-23 1993-01-23 Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.

Country Status (1)

Country Link
ES (1) ES2065254B1 (es)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044710A1 (en) * 1980-07-17 1982-01-27 Scripps Clinic And Research Foundation Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
ES2026826A6 (es) * 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados.
ES2029938A6 (es) * 1990-07-31 1992-10-01 Ercros Sa Metodo para la obtencion de peptidos y proteinas recombinantes de fusion de la subunidad vp2 de parvovirus canino cpv, y su empleo en metodos de diagnostico y en la fdormulacion de vacunas.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044710A1 (en) * 1980-07-17 1982-01-27 Scripps Clinic And Research Foundation Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
ES2029938A6 (es) * 1990-07-31 1992-10-01 Ercros Sa Metodo para la obtencion de peptidos y proteinas recombinantes de fusion de la subunidad vp2 de parvovirus canino cpv, y su empleo en metodos de diagnostico y en la fdormulacion de vacunas.
ES2026826A6 (es) * 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados.

Also Published As

Publication number Publication date
ES2065254B1 (es) 1995-07-16

Similar Documents

Publication Publication Date Title
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
DE3588022T3 (de) Pre-S genkodierte Hepatitis B Peptide und diese enthaltende Immunogene und Vakzine
HK1043475A1 (en) Compositions and methods for treating infections using analogues of indolicidin
NZ333500A (en) Vaccines comprising HIV gp120 envelope polypeptides from vaccinees vaccinated with an earlier HIV gp120 vaccine and subsequently infected with HIV
NO329875B1 (no) Isolert DNA-sekvens som koder for svinereproduktive- og respiratoriske syndromvirus (PRRSV), en sammensetning omfattende polypeptidene kodet av denne, en sammensetning for indusering av antistoffer mot PRRSV, anvendelse av sammensetning for fremstilling av vaksine og fremgangsmate for a skille PRRSV-stamme ISU-55 fra andre PRRSV-stammer.
ES2059565T3 (es) Virus mva de la vacuna, recombinante.
CY1111831T1 (el) Παραγωγα ογκο-συναφους αντιγονου απο την οικογενεια mage και αλληλουχιες νουκλεϊνικου οξεος που κωδικοποιουν αυτα, που χρησιμοποιουνται για την παρασκευη πρωτεϊνων συντηξης και συνθεσεων για εμβολιασμο
AU3234295A (en) Influenza virus subunit conjugates
CA2132742A1 (en) Synthetic Peptides and Vaccines Against Parvovirus
ATE302016T1 (de) Peptide, verwendet als träger in immunogenen konstrukten, die in der entwicklung synthetischer impfstoffe geeignet sind
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
AU2363301A (en) Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes
RU94040393A (ru) Синтетические пептиды для вакцины против краснухи
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
ES2065254A1 (es) Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.
ATE221786T1 (de) Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus
WO2000012122A3 (de) Niedermolekulare fragmente der hyaluronsäure zur herstellung von impfstoffen
HUP0202770A2 (hu) Humán papillómavírus oltóanyag
GB2299994A (en) Equine arteritis virus peptides antibodies and their use in a diagnostic test
ES1027961U (es) Soporte publicitario para carritos.
Alekseeva et al. Chemical fragmentation by o-iodosobenzoic acid of alpha-chain of histidine decarboxylase from Micrococcus sp. n. AT tryptophan residues.
ES2012815A6 (es) Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma, y para preparar vacunas que los contienen.
ES2089966A1 (es) Peptidos y vacunas sinteticas contra parvovirus.
EA199801032A1 (ru) Белки zona pellucida для контрацепции
BR0016740A (pt) Antìgenos de esporozoìto de cryptosporidium

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20141120